Clinical Trial

Preoperative Hypofractionated RT + Immunotherapy & Surgery for Retroperitoneal Sarcoma (FUSION-02)

Study acronym: FUSION-02
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
To investigate the feasibility and peri-operative complications of preoperative hypo-fractionated radiotherapy combined with immunotherapy followed by surgery for retroperitoneal sarcoma
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-01.
Trial Details
NCT Number NCT07396116
Lead Sponsor Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Conditions Soft Tissue Sarcoma (STS), Retroperitoneal Sarcoma, Immunotherapy, Radiotherapy Side Effect, Ultra-hypofractionated Radiotherapy
Enrollment 28 participants
Start Date 2026-02-12
Primary Completion 2028-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-12